Continuous glucose monitor metrics from five studies identify participants at risk for type 1 diabetes development
Calhoun P, Spanbauer C, Steck AK, et al.
Diabetologia. Pub. online 11 Feb 2025.
Leggi
Breaking news
Partnership and marriage and risk of type 2 diabetes: a narrative review
Kowall B, Rathmann W
Diabetologia. Pub. online 7 Feb 2025.
Leggi
Glucose-lowering medications and risk of chronic obstructive pulmonary disease exacerbations in patients with type 2 diabetes
Ray A, Paik JM, Wexler DJ, et al.
JAMA Intern Med. 2025:e247811.
Leggi
Adding social determinants of health to the equation: development of a cardiometabolic disease staging model using clinical and social determinants of health to predict type 2 diabetes
Howell CR, Tanaka S, Zhang L, et al.
Diabetes Obes Metab. Pub. online 10 Feb 2025.
Leggi
The real-life experiences of people living with overweight and obesity: a psychosocial perspective
Flint SW, Vázquez-Velázquez V, Le Brocq S, Brown A
Diabetes Obes Metab. Pub online 11 Feb 2025.
Leggi
Sex-specific blood pressure trajectories and cardiovascular disease in type 1 diabetes: 32-year follow-up of the pittsburgh epidemiology of diabetes complications cohort
Miller RG, Orchard TJ, Costacou T
Diabetes Care. 2025:dc242258.
Leggi
Quantitative comparison of glucagon-like peptide-1 receptor agonists on weight loss in adults: a systematic review and model-based meta-analysis
Zhang S, Yu B, Xu J, et al.
Diabetes Technol Ther. Pub. online 6 Feb 2025.
Leggi
Patient and physician factors driving the gaps in use of drugs with cardiovascular and kidney benefits by medicare beneficiaries with type 2 diabetes treated by endocrinologists, nephrologists, and cardiologists: population-based cohort study
McCoy RG, Vandergrift JL, Gray B
Diabetes Res Clin Pract. 2025:112039.
Leggi
Time in targeted blood glucose range as an independent predictor of 28-day mortality in ICU patients: a retrospective study
Zhao J, Huang D, Hua S, et al.
Diabetes Res Clin Pract. 2025:112033.
Leggi
Real-world evidence supporting the use of advanced hybrid closed loop in poorly controlled type 1 diabetes patients
Graf S, Hofer G, Hirschmann R, et al.
Diabetes Res Clin Pract. 2025:112035.
Leggi